Hospital General Universitario de Castellón
14
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
2 terminated/withdrawn out of 14 trials
60.0%
-26.5% vs industry average
7%
1 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)
Role: collaborator
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
Role: collaborator
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
Role: collaborator
Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.
Role: collaborator
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
Role: collaborator
Online Prevention of Emotional Disorders in Women Undergoing Fertility Treatments
Role: collaborator
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)
Role: collaborator
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
Role: collaborator
INOCA Spanish National Registry
Role: collaborator
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
Role: collaborator
Weaning From Mechanical Ventilation in Neurological Patients
Role: lead
Lactate and Complications in Cytoreduction Surgery for Peritoneal Carcinomatosis
Role: lead
Analgesic Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) Versus Placebo During the First Stage of Labor
Role: collaborator
Non-invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema
Role: lead
All 14 trials loaded